Track topics on Twitter Track topics that are important to you
National Osteoporosis Foundation PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest National Osteoporosis Foundation articles that have been published worldwide.
We have published hundreds of National Osteoporosis Foundation news stories on BioPortfolio along with dozens of National Osteoporosis Foundation Clinical Trials and PubMed Articles about National Osteoporosis Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of National Osteoporosis Foundation Companies in our database. You can also find out about relevant National Osteoporosis Foundation Drugs and Medications on this site too.
Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens: response to comments by Chen et al.
Worldwide, musculoskeletal (MSK) disorders are the second cause of living with disability. According to our data, in Mexico, MSK conditions are an important cause of disability, at national and state level. Preventive actions promoted by health systems to reduce the burden of MSK disorders are essential.
The antiresorptive potency varies between different bisphosphonates. We investigated the effect of stopping oral bisphosphonate treatment for postmenopausal osteoporosis (ibandronate, alendronate, risedronate) on BTMs and BMD. After stopping treatment, all three groups showed an increase in BTMs and a decrease in hip BMD; however, none returned to pre-treatment baseline values.
Surgical treatment of multiple vertebral fractures in patients with glucocorticoid-induced osteoporosis is difficult because of a high rate of secondary fracture postoperatively. A case is described in which initial treatment with teriparatide to improve osteoporosis followed by treatment of kyphosis with correction fusion achieved a favorable outcome.
This study investigated the effect of the N-methyladenosine (mA)-associated SNPs on bone mineral density (BMD) and found plenty of mA-SNPs that were associated with BMD. This study increases our understanding on the regulation patterns of SNP and may provide new clues for further detection of functional mechanism underlying the associations between SNPs and osteoporosis.
A poorer functional status at the time of fracture is a predictor of non-adherence to oral bisphosphonates initiated after a hip fracture, and suggests further opportunities for optimization of secondary fracture prevention in this high-risk population.